GSK and AstraZeneca are utilizing Manchester as a base for their talent pipeline development and early career scientist recruitment events.

1 report, 1 independent Updated Jun 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

GSK AstraZeneca Manchester

Keep exploring

Part of

Companies like BAE Systems, GSK, AstraZeneca, and HSBC are benefiting from geopolitical tensions, market recoveries, and strong market conditions in Europe.

Also in this story

All 5 developments

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
Manchester
city in Greater Manchester, England
- Andy Burnham won a by-election, becoming a Member of Parliament.Mon 16:42
- Government commits funds for station and service upgrades and ends the operator's contract, bringing the service into public ownership.Mon 08:39

Coverage

Newest first; wire copies grouped

Jun 29rsc.org